PT - JOURNAL ARTICLE AU - Arash Mostaghimi AU - M.-J. Antonini AU - Deborah Plana AU - Philip D. Anderson AU - Brandon Beller AU - Edward W. Boyer AU - Amber Fannin AU - Jacob Freake AU - Richard Oakley AU - Michael S. Sinha AU - Leanne Smith AU - Christopher Van AU - Helen Yang AU - Peter K. Sorger AU - Nicole R. LeBoeuf AU - Sherry H. Yu TI - Rapid prototyping and clinical testing of a reusable face shield for health care workers responding to the COVID-19 pandemic AID - 10.1101/2020.04.11.20061960 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.11.20061960 4099 - http://medrxiv.org/content/early/2020/04/15/2020.04.11.20061960.short 4100 - http://medrxiv.org/content/early/2020/04/15/2020.04.11.20061960.full AB - Due to supply chain disruption, the COVID-19 pandemic has caused severe shortages in personal protective equipment (PPE) for health care professionals. Local fabrication based on 3D printing is one way to address this challenge, particularly in the case of simple products such as protective face shields. As a consequence, many public domain designs for face shields have become available. No clear path exists, however, for introducing a locally fabricated and unapproved product into a clinical setting. In a US health care setting, face shields are regulated by the Food and Drug Administration (FDA); similar policies exist in other countries. We describe a research protocol under which rapid iteration on an existing design, coupled with clinical feedback and real-world testing in an emergency department, allowed a face shield to be implemented by the members of the incident command team at a major academic medical center. We describe our design and testing process and provide an overview of regulatory considerations associated with fabrication and testing of face shields and related products. All designs, materials used, testing protocols, and survey results are reported in full to facilitate the execution of similar face shield efforts in other clinical settings. Our work serves as a case study for development of a robust local response to pandemics and other health care emergencies, with implications for healthcare professionals, hospital administrators, regulatory agencies and concerned citizens.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLocal fabricators, makers and citizens generously donated their time and resources and were essential for all stages of the project. This work was also supported by the Harvard MIT Center for Regulatory Sciences and by NIH/NCI grants U54-CA225088 (to PKS, NL and DP) and by T32-GM007753 (to DP) and by the Harvard Ludwig Center. MJA is a recipient of the Friends of McGovern Graduate Fellowship.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe designs generated during this study are included in this published article (and its supplementary information files). The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.